Interstitial Cystitis

• FDA approval · 2008-07-28
  FDA Approved: RIMSO-50 — Supplemental Application (Mylan Institutional LLC)

  The FDA approved a supplemental application for RimSO-50 (dimethyl sulfoxide) submitted by Mylan Institutional LLC.

• FDA approval · 2008-07-24
  FDA Approved: ELMIRON — Supplemental Application (Janssen Pharmaceuticals, Inc.)

  FDA approved a supplemental application for ELMIRON (pentosan polysulfate sodium) submitted by Janssen Pharmaceuticals, Inc. The action upda…

• CLINICAL_TRIALS research · 2006-10-09
  Clinical Trial Update: Analysis of Expression of Nitric Oxide Syntheses and Their Functional Role in Human Urothelium

  A terminated clinical trial analyzing the expression and role of nitric oxide synthases in human urothelium, with indications including inte…

• CLINICAL_TRIALS trial_result · 2006-09-29
  Clinical Trial Update: Study of U101 for Bladder Pain and/or Urgency [Phase 2]

  Phase 2 study of U101 for bladder pain and urgency in pelvic pain and interstitial cystitis has completed.

• FDA approval · 2006-09-20
  FDA Approved: ELMIRON — Supplemental Application (Janssen Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for ELMIRON (pentosan polysulfate sodium) from Janssen Pharmaceuticals, Inc.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.